Replimune Group
REPL
108 hedge funds and large institutions have $1.06B invested in Replimune Group in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 45 increasing their positions, 32 reducing their positions, and 18 closing their positions.
41% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 32
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.12% less ownership
Funds ownership: 75.03% → 74.91% (-0.12%)
4% less funds holding
Funds holding: 112 → 108 (-4)
19% less capital invested
Capital invested by funds: $1.32B → $1.06B (-$252M)
22% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 18
94% less call options, than puts
Call options by funds: $189K | Put options by funds: $3.27M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$29.1M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$17.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$16.9M |
| 4 |
State Street
Boston,
Massachusetts
|
+$11.5M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$8.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$47.3M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$25.5M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$16.1M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$7.92M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.36M |
REPL Hedge Fund Activity: Q1 2021 in Review
108 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q1 2021, worth a combined $1.06B — down 19% from $1.32B a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of REPL and 14 opened new positions — a net loss of 4 holders — while 32 trimmed existing stakes and 45 added.
The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $29.1M. The largest seller was Fidelity Investments, cutting an estimated $47.3M.
- 108 institutional investors held Replimune Group (REPL) as of Q1 2021, down from 112 in Q4 2020.
- Funds reported $1.06B of Replimune Group stock for Q1 2021, down 19% quarter-over-quarter.
- 14 funds opened new Replimune Group positions in Q1 2021 and 18 closed out, a net change of -4 holders.
- The largest Replimune Group buyer in Q1 2021 was Loomis, Sayles & Company, an estimated $29.1M added.
- The largest Replimune Group seller in Q1 2021 was Fidelity Investments, an estimated $47.3M sold.
Based on aggregated 13F filings for Q1 2021.